Stability of Myrmecia pilosula (Jack Jumper) Ant venom for use in immunotherapy

2010/09/04 by Michael D. Wiese, Noel W. Davies, Tim K. Chataway +6 · 3 citations
Agricultural and Biological Sciences · Chemistry · Medicine · #Allergic Rhinitis and Sensitization #Biochemistry #Chemistry #Chromatography #Food Allergy and Anaphylaxis Research #Glycerol #Insect and Pesticide Research #Jumper #Sucrose #Venom

paper · doi:10.1016/j.jpba.2010.08.024

openalex publication_date 2010/09/04 · crossref created 2010/09/04 · crossref issued 2011/01/01 · crossref published 2011/01/01 · crossref published-print 2011/01/01 · crossref deposited 2018/12/08 · openalex created_date 2025/10/10 · crossref indexed 2026/03/09 · openalex updated_date 2026/07/28

Citations

• Prevalence, severity, and natural history of jack jumper ant venom allergy in Tasmania
• Myrmecia pilosula (Jack Jumper) ant venom: Validation of a procedure to standardise an allergy vaccine

Cited by

• Causes of ant sting anaphylaxis in Australia: the Australian Ant Venom Allergy Study
• Ultrarush versus semirush initiation of insect venom immunotherapy: A randomized controlled trial
• Myrmecia (ant) [wikipedia]